We offer in-practice and virtual consultations
Rather than focusing solely on their benefits, many sessions examine how to: Mitigate muscle loss Improve durability of response Enhance patient adherence Support transition into long-term maintenance strategies In this sense, GLP-1s are no longer the end point, they are part of a broader, more sophisticated therapeutic ecosystem
No, shortness of breath is not listed as a common or characteristic side effect in FDA prescribing information for GLP-1 medications
Semaglutide, the primary ingredient in many weight loss drugs, mimics the natural GLP-1 hormone, promoting satiety and aiding in blood glucose regulation
We look at the full picture
The medical director of the VCU Health Medical Weight Loss Program explains what these medications do to the body and why they might not be suited for everyone